Antisense therapeutics phase ii clinical trial of atl1102 is fully enrolled now


5 ASX Companies Leveraging AI to Drive Growth in 2024

Recent Articles

 Lufax Announces Annual General Meeting on May 30, 2024 and Filing of Its Annual Report on Form 20-F
April 23, 2024 11:05 PM AEST | By Cision

 China's economy in 2024: Pleasing outcomes among uncertainties
April 23, 2024 11:00 PM AEST | By Cision

 STUDIO PILATES INTERNATIONAL ANNOUNCES 100TH STUDIO, WITH CONTINUED EXPANSION AND MILESTONE OPENING
April 23, 2024 11:00 PM AEST | By Cision

 Grand Stevie Winners Announced in 2024 Asia-Pacific Stevie® Awards
April 23, 2024 11:00 PM AEST | By Cision

 RPX Corporation Launches RPX Empower
April 23, 2024 11:00 PM AEST | By Cision


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.